NCT06640101 Effects of Inspiratory Muscle Training on Stroke Rehabilitation Outcomes
| NCT ID | NCT06640101 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hong Kong Metropolitan University |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 84 participants |
| Start Date | 2025-02-21 |
| Primary Completion | 2025-10-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 84 participants in total. It began in 2025-02-21 with a primary completion date of 2025-10-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is designed to explore the effects of a 4-week protocol of inspiratory muscle training (IMT) at 50% maximum inspiratory pressure (MIP) on respiratory function, diaphragm thickness, balance control, exercise capacity, and quality of life in people after stroke. To ascertain the effect of IMT on the relationship between diaphragm muscle contraction and activation of other trunk muscles, this study also explores whether any effect of the 4-week IMT protocol on balance control is associated with changes in the anticipatory posture adjustments (APAs) time - the onset time of postural muscles during a required task (e.g., the rapid shoulder flexion test).
Eligibility Criteria
Inclusion Criteria: * Age ≥ 40 years and \< 80 years; * breathing spontaneously; * clinically diagnosed with ischemic and/or haemorrhagic stroke; * duration of stroke from onset falls within 1 month to 12 months after diagnosis; * no thoracic or abdominal surgery within the last 6 months; * able to understand and follow verbal instructions; * no facial palsy, or mild facial palsy without limitation of labial occlusion; * able to maintain a resting sitting posture without feet support for at least 30 seconds; * no cognitive impairment (Montreal Cognitive Assessment (MoCA) score ≥ 26); * able to independently walk at least 10 meters with or without an assistive device. Exclusion Criteria: * acute myocardial infarction or acute heart failure; * acute pain in any part of the body; * with respiratory illness or positive clinical signs of impaired respiratory function (such as shortness of breath, hypoxemia, chronic cough and sputum retention); * with chronic cardiovascular dysfunction; * Trunk Impairment Scale (TIS) score ≥ 20. * patient with a nasal feeding tube, tracheal tube and/or any condition that prevents the measurement or the implementation of the study procedure.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06640101 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 80 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06640101 currently recruiting?
Yes, NCT06640101 is actively recruiting participants. Contact the research team at s1350035@live.hkmu.edu.hk for enrollment information.
Where is the NCT06640101 trial being conducted?
This trial is being conducted at Shenzhen, China.
Who is sponsoring the NCT06640101 clinical trial?
NCT06640101 is sponsored by Hong Kong Metropolitan University. The trial plans to enroll 84 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.